GO:0004021 L-alanine:2-oxoglutarate transaminase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004021 defines the reversible pyridoxal phosphate-dependent transamination of L-alanine with 2-oxoglutarate to yield pyruvate and L-glutamate.
• The enzyme is widely known as alanine aminotransferase (ALT/GPT) and is a classical serum biomarker of hepatocellular injury.
• Multiple isozymes and electrophoretic variants exist in human liver and in plants such as maize and tomato.
• Subcellular localization differs between tissues, with mitochondrial and cytosolic forms influencing glutamine and glutamate oxidation.
• Kinetic properties can be complex and substrate-dependent, as shown for the maize embryo enzyme.
• CRISPR knockout, point-mutation, knock-in and overexpression models enable causal dissection of ALT/GPT function in disease and metabolism.
Description
L-alanine:2-oxoglutarate transaminase activity (GO:0004021) is a molecular function that catalyzes the reversible transfer of an amino group from L-alanine to 2-oxoglutarate, producing pyruvate and L-glutamate. This reaction is central to amino acid metabolism and links alanine, pyruvate, glutamate and tricarboxylic acid cycle intermediates. The enzyme responsible is commonly called alanine aminotransferase (ALT) or glutamate-pyruvate transaminase (GPT), and it requires pyridoxal phosphate as a cofactor. Because ALT activity is abundant in liver, it has become one of the most widely used clinical biomarkers of hepatocyte damage. Beyond clinical diagnostics, ALT activity is studied in plants, where isozymes and kinetic variants have been characterized in maize and tomato. In mammals, subcellular localization of ALT influences glutamine and glutamate oxidation in enterocytes and other tissues. Researchers investigating metabolic reprogramming, liver disease, and amino acid flux therefore need reliable tools to manipulate and measure this activity.
L-alanine:2-oxoglutarate transaminase activity At A Glance
| GO ID | GO:0004021 |
|---|---|
| GO term | L-alanine:2-oxoglutarate transaminase activity |
| Ontology | molecular_function |
| Synonym | Alanine aminotransferase activity; ALT; GPT; glutamic-pyruvic transaminase activity |
| Major function | Reversible transamination of L-alanine with 2-oxoglutarate to pyruvate and L-glutamate |
| Cofactor | Pyridoxal phosphate (PLP) |
| Reaction | L-alanine + 2-oxoglutarate = pyruvate + L-glutamate |
| Subcellular localization | Cytosolic and mitochondrial forms reported in mammalian tissues |
| Clinical relevance | Serum ALT is a standard biomarker of hepatocellular injury |
What Is GO:0004021?
GO:0004021 describes the catalysis of the reaction L-alanine + 2-oxoglutarate = pyruvate + L-glutamate. In this reversible transamination, the amino group of L-alanine is transferred to 2-oxoglutarate, generating pyruvate and L-glutamate. The activity is pyridoxal phosphate-dependent and is synonymous with alanine aminotransferase (ALT), glutamic-pyruvic transaminase (GPT), and several related names listed in QuickGO.
Why Is L-alanine:2-oxoglutarate transaminase activity Important in Cell Biology?
L-alanine:2-oxoglutarate transaminase activity is important because it sits at the intersection of amino acid catabolism, gluconeogenesis and nitrogen handling, and because its measurement in serum is a cornerstone of liver disease diagnosis and monitoring. The enzyme also participates in glutamine and glutamate oxidation pathways in tissues such as enterocytes, where its subcellular localization helps determine metabolic fate. In plants, ALT activity supports nitrogen recycling and has been characterized as multiple isozymes with distinct kinetic properties. Consequently, understanding this activity is relevant to hepatology, metabolic engineering, plant physiology and comparative enzymology.
• Provides a major route for alanine-derived pyruvate entry into gluconeogenesis and energy metabolism.
• Serum ALT activity is a routine clinical biomarker for hepatocellular injury and liver disease.
• Contributes to glutamine and glutamate oxidation in enterocyte mitochondria.
• Exists as multiple isozymes and electrophoretic variants in human liver.
• Plant ALT isozymes support nitrogen metabolism in maize and tomato.
• Kinetic complexity of plant ALT enzymes informs enzyme evolution and regulation.
• Pyridoxal phosphate dependence links ALT activity to vitamin B6 biology.
• Subcellular localization differences affect metabolic channeling in tissues.
• Enables comparative studies of transaminase function across species.
• Supports development of CRISPR models for causal testing of ALT/GPT genes.
Molecular Mechanism of L-alanine:2-oxoglutarate transaminase activity
Substrate binding and Schiff base formation
In simple terms: The enzyme first grabs the amino group from alanine using a vitamin B6-derived helper.
L-alanine:2-oxoglutarate transaminase activity requires pyridoxal phosphate (PLP) as a cofactor, which forms a Schiff base with the amino group of L-alanine. This step converts the enzyme-bound cofactor into pyridoxamine phosphate and releases pyruvate. The reaction is reversible and follows a ping-pong bi-bi kinetic mechanism typical of many transaminases.
Amino group transfer to 2-oxoglutarate
In simple terms: The amino group picked up from alanine is handed over to 2-oxoglutarate to make glutamate.
In the second half-reaction, the amino group stored on pyridoxamine phosphate is transferred to 2-oxoglutarate, yielding L-glutamate and regenerating the pyridoxal phosphate form of the enzyme. This completes the reversible interconversion of L-alanine and 2-oxoglutarate to pyruvate and L-glutamate.
Isozyme and variant diversity
In simple terms: Different versions of the enzyme can exist in the same tissue, with slightly different behaviors.
Electrophoretic and kinetic characterization of human liver soluble cytoplasmic L-alanine:2-oxoglutarate aminotransferase identified three variants, indicating heterogeneity in charge and catalytic properties. In maize, isozyme analysis revealed multiple forms of the enzyme, and the maize embryo enzyme displayed complex kinetic properties for L-alanine. Tomato ALT has also been partially purified and characterized.
Subcellular localization and metabolic context
In simple terms: Where the enzyme sits inside the cell affects what it does metabolically.
Subcellular localization studies in rat enterocytes showed that L-alanine aminotransferase and L-aspartate aminotransferase are distributed in a way that influences L-glutamine and L-glutamate oxidation by mitochondria. This compartmentation helps route amino groups and carbon skeletons between cytosol and mitochondria.
Cofactor and inhibition
In simple terms: The enzyme depends on a vitamin B6 derivative and can be blocked by certain inhibitors.
Pyridoxal phosphate is essential for transaminase activity, and its role in liver disease has been reviewed. L-cycloserine, an inhibitor of pyridoxal phosphate-dependent enzymes, affects brain GABA metabolism, illustrating how transaminase inhibition can alter amino acid neurotransmitter pathways.
Key Genes Involved in GO:0004021 L-alanine:2-oxoglutarate transaminase activity
The genes and proteins below are directly or indirectly associated with L-alanine:2-oxoglutarate transaminase activity across human, animal and plant systems.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GPT (ALT1) | Cytosolic alanine aminotransferase | Primary serum biomarker of liver injury |
| GPT2 (ALT2) | Mitochondrial alanine aminotransferase | Glutamate and glutamine metabolism |
| GOT1 | Aspartate aminotransferase, cytosolic | Related transaminase in nitrogen shuttling |
| GOT2 | Aspartate aminotransferase, mitochondrial | Related transaminase in nitrogen shuttling |
| Maize ALT isozymes | Plant alanine aminotransferase variants | Isozyme diversity and kinetics |
| Maize embryo ALT | Embryo-specific alanine aminotransferase | Complex kinetics for L-alanine |
| Tomato ALT | Plant alanine aminotransferase | Partial purification and characterization |
| Human liver ALT variants | Electrophoretic variants of cytosolic ALT | Variant characterization in human tissue |
| Pyridoxal kinase | Generates PLP cofactor | Cofactor supply for transaminases |
| GABA-T | GABA transaminase, PLP-dependent | Inhibited by L-cycloserine |
| Glutamate dehydrogenase | Links glutamate to TCA cycle | Context for ALT flux |
| Glutaminase | Produces glutamate from glutamine | Enterocyte glutamine oxidation |
| Alanine dehydrogenase | Alternative alanine metabolism | Comparative pathway context |
| Lactate dehydrogenase | Pyruvate to lactate conversion | Redox balance with ALT |
| Pyruvate carboxylase | Pyruvate to oxaloacetate | Gluconeogenic fate of pyruvate |
| PEPCK | Gluconeogenesis | Downstream use of pyruvate |
| BCKDH complex | Branched-chain amino acid catabolism | Related nitrogen handling |
How Is L-alanine:2-oxoglutarate transaminase activity Regulated?
L-alanine:2-oxoglutarate transaminase activity is regulated at multiple levels. Enzyme activity depends on pyridoxal phosphate availability, and the transaminase reaction is reversible and subject to substrate and product concentrations. In mammalian tissues, cytosolic and mitochondrial isozymes are differentially expressed, and their subcellular localization influences glutamine and glutamate oxidation. In plants, multiple isozymes with distinct kinetic properties provide additional regulatory flexibility. Inhibitors such as L-cycloserine can suppress PLP-dependent transaminases, altering GABA metabolism.
L-alanine:2-oxoglutarate transaminase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GPT (ALT1) | Hepatocellular injury biomarker | CRISPR knockout hepatocyte cell lines |
| GPT2 (ALT2) | Mitochondrial amino acid metabolism | Knockout and tagged knock-in models |
| GOT1/GOT2 | Nitrogen shuttling in liver and gut | Point-mutation and overexpression models |
| GABA-T | GABA metabolism and neurological function | L-cycloserine treatment and knockout models |
| Maize ALT isozymes | Plant nitrogen metabolism | Plant gene editing and overexpression |
Liver disease and hepatocellular injury
Serum alanine aminotransferase activity is a widely used biomarker of hepatocellular injury, and its elevation reflects leakage from damaged hepatocytes. The pyridoxal phosphate and transaminase relationship in liver disease has been reviewed in detail. Measuring ALT activity remains central to diagnosing and monitoring hepatitis, steatosis and drug-induced liver injury.
Metabolic and neurological implications
Because ALT activity interconverts alanine, pyruvate, glutamate and 2-oxoglutarate, it affects nitrogen balance and neurotransmitter precursor pools. Inhibition of PLP-dependent transaminases by L-cycloserine alters brain GABA metabolism, linking this activity class to neurological function. Subcellular localization of ALT in enterocytes further affects glutamine and glutamate oxidation, with implications for gut and whole-body metabolism.
Plant nitrogen metabolism
In maize and tomato, ALT isozymes participate in nitrogen recycling and amino acid metabolism, and their kinetic properties have been characterized. These plant enzymes are relevant to crop nitrogen use efficiency and metabolic engineering, although direct disease links are not established in the cited literature.
From L-alanine:2-oxoglutarate transaminase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is GPT required for alanine-derived gluconeogenesis? | CRISPR knockout in hepatocyte cell lines |
| Does a specific ALT variant alter catalytic efficiency? | Point-mutation knock-in of catalytic residues |
| Where does ALT localize in live cells? | Tagged knock-in with fluorescent protein |
| Does ALT overexpression change pyruvate flux? | Doxycycline-inducible overexpression |
| Which genes buffer loss of ALT activity? | CRISPR library screening and transcriptomics |
| Does ALT inhibition alter GABA levels? | Pharmacological inhibition with L-cycloserine |
How to Study the L-alanine:2-oxoglutarate transaminase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Coupled enzymatic assay | ALT activity via NADH oxidation | Serum and tissue ALT quantification |
| Electrophoresis | Charge variants and isozymes | Human liver ALT variant analysis |
| Enzyme kinetics | Substrate affinity and reaction rates | Maize and tomato ALT characterization |
| Subcellular fractionation | Cytosolic vs mitochondrial localization | Enterocyte metabolism studies |
| CRISPR knockout | Loss-of-function phenotype | Causal gene testing |
| Point-mutation knock-in | Effect of specific residues | Catalytic mechanism studies |
| Overexpression | Gain-of-function effects | Metabolic flux analysis |
Enzymatic activity assays
Classical ALT activity assays measure the conversion of L-alanine and 2-oxoglutarate to pyruvate and L-glutamate, often coupling pyruvate production to lactate dehydrogenase and NADH oxidation. These assays remain the standard for quantifying L-alanine:2-oxoglutarate transaminase activity in serum and tissue lysates.
Electrophoretic and kinetic characterization
Electrophoretic separation and kinetic analysis have been used to identify ALT variants and isozymes in human liver and maize. Such methods reveal differences in charge, substrate affinity and catalytic behavior among enzyme forms.
Subcellular fractionation
Subcellular fractionation studies have localized ALT and aspartate aminotransferase to cytosolic and mitochondrial compartments in rat enterocytes, helping define their metabolic roles.
CRISPR-based functional genomics
CRISPR knockout, point-mutation and overexpression models allow causal testing of ALT/GPT gene function in cell lines and animal models. These approaches can be combined with metabolomics and transcriptomics to link genotype to metabolic phenotype.
How CRISPR Can Be Used to Study GO:0004021 L-alanine:2-oxoglutarate transaminase activity
Knockout
CRISPR knockout of GPT or GPT2 can eliminate L-alanine:2-oxoglutarate transaminase activity in cell models, enabling studies of alanine and pyruvate flux, gluconeogenesis and nitrogen handling. Knockout hepatocyte lines are useful for validating ALT as a biomarker and for identifying compensatory pathways.
Point Mutation
Point-mutation knock-in can alter catalytic residues or cofactor-binding sites of ALT/GPT, allowing precise testing of mechanism and of variant effects observed in human liver. Such models help distinguish loss of activity from loss of protein.
Knock-in
Tagged knock-in of endogenous GPT or GPT2 with fluorescent or affinity tags enables live-cell localization and interaction studies, building on subcellular fractionation findings. Knock-in of disease-associated variants can model altered enzyme behavior.
Overexpression
Overexpression of ALT/GPT in cell lines or tissues can increase transamination flux and alter glutamate, pyruvate and alanine pools. This is useful for metabolic engineering and for testing whether increased activity is sufficient to drive downstream phenotypes.
How EDITGENE Supports L-alanine:2-oxoglutarate transaminase activity Research
Researchers studying L-alanine:2-oxoglutarate transaminase activity-related genes often need to determine whether a candidate gene is causally involved in a metabolic or disease phenotype. EDITGENE provides CRISPR-based cell models and screening services to test these hypotheses rigorously.
Contact EDITGENE today to design your custom CRISPR model for L-alanine:2-oxoglutarate transaminase activity research.
Frequently Asked Questions About L-alanine:2-oxoglutarate transaminase activity
What is L-alanine:2-oxoglutarate transaminase activity?
It is the pyridoxal phosphate-dependent catalysis of L-alanine plus 2-oxoglutarate to pyruvate plus L-glutamate, also known as alanine aminotransferase (ALT) or GPT activity.
What is the GO ID for alanine aminotransferase activity?
The Gene Ontology identifier is GO:0004021, with the official name L-alanine:2-oxoglutarate transaminase activity.
What genes are involved in L-alanine:2-oxoglutarate transaminase activity?
Key genes include GPT (ALT1) and GPT2 (ALT2) in mammals, plus plant ALT isozymes in maize and tomato.
Why is ALT activity used as a liver biomarker?
Because ALT is abundant in hepatocytes and leaks into serum upon liver injury, serum ALT activity is a standard biomarker of hepatocellular damage.
Does L-alanine:2-oxoglutarate transaminase require a cofactor?
Yes, it requires pyridoxal phosphate (vitamin B6 derivative) as a cofactor for the transamination reaction.
Are there different isozymes of alanine aminotransferase?
Yes, cytosolic and mitochondrial forms exist, and multiple electrophoretic variants have been described in human liver and maize.
How is ALT activity measured in the laboratory?
It is commonly measured by coupled enzymatic assays that detect pyruvate production, often through lactate dehydrogenase and NADH oxidation.
Can ALT activity be inhibited?
Yes, inhibitors of pyridoxal phosphate-dependent enzymes such as L-cycloserine can suppress transaminase activity and alter GABA metabolism.
What is the role of ALT in plant metabolism?
Plant ALT isozymes participate in nitrogen recycling and amino acid metabolism, as characterized in maize and tomato.
How can CRISPR help study L-alanine:2-oxoglutarate transaminase activity?
CRISPR knockout, point-mutation, knock-in and overexpression models allow causal testing of ALT/GPT gene function in metabolism and disease.
Conclusion
L-alanine:2-oxoglutarate transaminase activity (GO:0004021) is a fundamental pyridoxal phosphate-dependent transamination reaction with broad relevance to liver disease, amino acid metabolism and plant nitrogen handling. Its clinical importance as the ALT biomarker and its multiple isozymes and variants make it a compelling target for mechanistic and translational research. CRISPR-based cell models provide a rigorous path to determine how ALT/GPT genes contribute to metabolic and disease phenotypes.
References
- 1. Kanemitsu F et al.. 1990. Electrophoretic and kinetic characterization of three variants of soluble cytoplasmic L-alanine:2-oxoglutarate aminotransferase in human liver tissue.. Clin Biochem 23(2):121-5 PMID: 2372927
- 2. Martín M et al.. 1976. [L-alanine: 2-ketoglutarate aminotransferase from maize embryo with complex kinetic properties for l-alanine (author's transl)].. Rev Esp Fisiol 32(2):131-6 PMID: 935623
- 3. Watson NR et al.. 1992. Analysis of L-alanine:2-oxoglutarate aminotransferase isozymes in maize.. Biochem Genet 30(7-8):371-83 PMID: 1445181
- 4. Wood JD et al.. 1978. Effect of L-cycloserine on brain GABA metabolism.. Can J Physiol Pharmacol 56(1):62-8 PMID: 638858
- 5. Rech J et al.. 1974. Partial purification and initial studies of the tomato L-alanine:2-oxoglutarate aminotransferase.. Biochim Biophys Acta 350(2):392-9 PMID: 4847569
- 6. Vanderlinde RE. 1986. Review of pyridoxal phosphate and the transaminases in liver disease.. Ann Clin Lab Sci 16(2):79-93 PMID: 3008634
- 7. Masola B et al.. 1985. Transamination pathways influencing L-glutamine and L-glutamate oxidation by rat enterocyte mitochondria and the subcellular localization of L-alanine aminotransferase and L-aspartate aminotransferase.. Biochim Biophys Acta 843(1-2):137-43 PMID: 2865979
